These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1593354)

  • 1. Pituitary gigantism caused by growth hormone excess from infancy.
    Gelber SJ; Heffez DS; Donohoue PA
    J Pediatr; 1992 Jun; 120(6):931-4. PubMed ID: 1593354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
    Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
    Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenoma associated with gigantism and hyperprolactinemia.
    Alikasifoglu A; Kandemir N; Akalan N; Yordam N
    Pediatr Neurosurg; 2001 Dec; 35(6):325-8. PubMed ID: 11786701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary gigantism causing diabetic ketoacidosis.
    Alvi NS; Kirk JM
    J Pediatr Endocrinol Metab; 1999; 12(6):907-9. PubMed ID: 10614552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.
    Felix IA; Horvath E; Kovacs K; Smyth HS; Killinger DW; Vale J
    Acta Neuropathol; 1986; 71(1-2):76-82. PubMed ID: 3776476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gigantism associated with a pituitary tumour secreting growth hormone and prolactin and cured by transsphenoidal hypophysectomy.
    Favre L; Rogers LM; Cobb CA; Rabin D
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):193-200. PubMed ID: 223354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gigantism due to growth hormone excess in a boy with optic glioma.
    Drimmie FM; MacLennan AC; Nicoll JA; Simpson E; McNeill E; Donaldson MD
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):535-8. PubMed ID: 11012581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma.
    Müssig K; Gallwitz B; Honegger J; Strasburger CJ; Bidlingmaier M; Machicao F; Bornemann A; Ranke MB; Häring HU; Petersenn S
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):198-202. PubMed ID: 17427111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
    Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism.
    Dubuis JM; Deal CL; Drews RT; Goodyer CG; Lagacé G; Asa SL; Van Vliet G; Collu R
    Clin Endocrinol (Oxf); 1995 May; 42(5):539-49. PubMed ID: 7621575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary gigantism.
    Lu PW; Silink M; Johnston I; Cowell CT; Jimenez M
    Arch Dis Child; 1992 Aug; 67(8):1039-41. PubMed ID: 1520009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine evaluation and indications for surgery of functional pituitary adenomas.
    Pearson OH; Brodkey JS; Kaufman B
    Clin Neurosurg; 1974; 21():26-38. PubMed ID: 4370760
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pituitary adenomas. Surgical treatment by transphenoidal approach].
    Somma M; Rasio E; Beauregard H; Hardy J
    Union Med Can; 1980 Jan; 109(1):68-81. PubMed ID: 6247803
    [No Abstract]   [Full Text] [Related]  

  • 14. The acromegaly--gigantism syndrome. Report of four cases treated surgically.
    Zampieri P; Scanarini M; Sicolo N; Andrioli G; Mingrino S
    Surg Neurol; 1983 Dec; 20(6):498-503. PubMed ID: 6648790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete biochemical control and pituitary adenoma disappearance in a child with gigantism: efficacy of octreotide therapy.
    Ciresi A; Amato MC; Galluzzo A; Giordano C
    J Endocrinol Invest; 2011 Feb; 34(2):162-3. PubMed ID: 21502798
    [No Abstract]   [Full Text] [Related]  

  • 16. Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy.
    Bergamaschi S; Ronchi CL; Giavoli C; Ferrante E; Verrua E; Ferrari DI; Lania A; Rusconi R; Spada A; Beck-Peccoz P
    Horm Res Paediatr; 2010; 73(1):74-9. PubMed ID: 20190543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting peptidomimergic control of gigantism caused by pituitary acidophilic stem cell adenoma.
    Maheshwari HG; Prezant TR; Herman-Bonert V; Shahinian H; Kovacs K; Melmed S
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3409-16. PubMed ID: 10999842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth pituitary adenomas: evaluation of 20 patients].
    Tella OI; Herculano MA; Delcello R; Aguiar PH
    Arq Neuropsiquiatr; 2002 Mar; 60(1):123-8. PubMed ID: 11965421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological and experimental investigations in a case of gigantism.
    Fazekas I; Pásztor E; Slowik F; Bálint K; Dobronyi I; Bácsy E; Gyévai A; Péter F; Blatniczky L; Varga I
    Acta Neuropathol; 1993; 85(2):167-74. PubMed ID: 8382895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gigantism caused by a double-secreting (GH-PRL) acidophile adenoma in a 6-year-old girl].
    Rusconi R; Ballabio G; Piceni Sereni L
    Minerva Pediatr; 1985 Oct; 37(20):815-9. PubMed ID: 3005820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.